Skip to main content
Erschienen in: Trials 1/2020

Open Access 01.12.2020 | Correction

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

verfasst von: Grazia Daniela Femminella, Eleni Frangou, Sharon B. Love, Gail Busza, Clive Holmes, Craig Ritchie, Robert Lawrence, Brady McFarlane, George Tadros, Basil H. Ridha, Carol Bannister, Zuzana Walker, Hilary Archer, Elizabeth Coulthard, Ben R. Underwood, Aparna Prasanna, Paul Koranteng, Salman Karim, Kehinde Junaid, Bernadette McGuinness, Ramin Nilforooshan, Ajay Macharouthu, Andrew Donaldson, Simon Thacker, Gregor Russell, Naghma Malik, Vandana Mate, Lucy Knight, Sajeev Kshemendran, John Harrison, Christian Hölscher, David J. Brooks, Anthony Peter Passmore, Clive Ballard, Paul Edison

Erschienen in: Trials | Ausgabe 1/2020

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
Grazia Daniela Femminella and Eleni Frangou contributed equally to this work.
The original article can be found online at https://​doi.​org/​10.​1186/​s13063-019-3259-x.
Correction to: Trials (2019) 20: 191
https://doi.org/10.1186/s13063-019-3259-x
After publication of our article [1] the authors have notified us that the name of Prof. Christian Hölscher had been inadvertently forgotten when compiling the list of authors. Dr. Hölscher developed the concept of testing liraglutide in Alzheimer’s mouse model, has done the preclinical experiments, and is a co-applicant of the Alzheimer Society UK grant that partially funds the study.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
verfasst von
Grazia Daniela Femminella
Eleni Frangou
Sharon B. Love
Gail Busza
Clive Holmes
Craig Ritchie
Robert Lawrence
Brady McFarlane
George Tadros
Basil H. Ridha
Carol Bannister
Zuzana Walker
Hilary Archer
Elizabeth Coulthard
Ben R. Underwood
Aparna Prasanna
Paul Koranteng
Salman Karim
Kehinde Junaid
Bernadette McGuinness
Ramin Nilforooshan
Ajay Macharouthu
Andrew Donaldson
Simon Thacker
Gregor Russell
Naghma Malik
Vandana Mate
Lucy Knight
Sajeev Kshemendran
John Harrison
Christian Hölscher
David J. Brooks
Anthony Peter Passmore
Clive Ballard
Paul Edison
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04608-4

Weitere Artikel der Ausgabe 1/2020

Trials 1/2020 Zur Ausgabe